Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 1 | $313,948 |
| Sells | 44 | $21,426,780 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Mar 2025 17:35 | CRSP | CRISPR Therapeutics AG | PRASAD RAJU | Chief Financial Officer | 17 Mar 2025 | Sale | 3,762 | 41.8 | 157,252 | D |
| 12 Mar 2025 19:05 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 11 Mar 2025 | Sale | 9,973 | 42.42 | 423,055 | D |
| 12 Mar 2025 19:05 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 12 Mar 2025 | Sale | 4,462 | 43.32 | 193,294 | D |
| 12 Mar 2025 19:05 | CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 11 Mar 2025 | Sale | 2,850 | 42.42 | 120,897 | D |
| 12 Mar 2025 19:05 | CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 12 Mar 2025 | Sale | 1,116 | 43.32 | 48,345 | D |
| 12 Mar 2025 19:05 | CRSP | CRISPR Therapeutics AG | BRUNO JULIANNE | Chief Operating Officer | 11 Mar 2025 | Sale | 1,198 | 42.42 | 50,819 | D |
| 12 Mar 2025 19:05 | CRSP | CRISPR Therapeutics AG | BRUNO JULIANNE | Chief Operating Officer | 12 Mar 2025 | Sale | 190 | 43.32 | 8,231 | D |
| 28 Feb 2025 17:35 | CRSP | CRISPR Therapeutics AG | GREENE JOHN | Director | 26 Feb 2025 | Purchase | 7,000 | 44.8497 | 313,948 | D |
| 21 Feb 2025 17:35 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 19 Feb 2025 | Sale | 18,360 | 55.205 | 1,013,564 | D |
| 19 Feb 2025 17:35 | CRSP | CRISPR Therapeutics AG | BRUNO JULIANNE | Chief Operating Officer | 19 Feb 2025 | Sale | 333 | 52.8 | 17,582 | D |
| 19 Feb 2025 17:35 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 18 Feb 2025 | Sale | 11,640 | 55.05 | 640,782 | D |
| 19 Feb 2025 17:35 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 19 Feb 2025 | Sale | 6,928 | 52.8 | 365,798 | D |
| 19 Feb 2025 17:35 | CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 18 Feb 2025 | Sale | 9,595 | 53.85 | 516,691 | D |
| 19 Feb 2025 17:35 | CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 19 Feb 2025 | Sale | 1,947 | 52.8 | 102,802 | D |
| 04 Dec 2024 17:35 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 02 Dec 2024 | Sale | 15,000 | 55.1043 | 826,564 | D |
| 13 Nov 2024 17:35 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 11 Nov 2024 | Sale | 23,121 | 55.43 | 1,281,597 | D |
| 13 Nov 2024 17:35 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 11 Nov 2024 | Sale | 6,879 | 56.27 | 387,081 | D |
| 15 Oct 2024 18:00 | CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 14 Oct 2024 | Sale | 1,089 | 46.28 | 50,399 | D |
| 15 Oct 2024 18:00 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 14 Oct 2024 | Sale | 4,293 | 46.28 | 198,680 | D |
| 24 Jun 2024 17:35 | CRSP | CRISPR Therapeutics AG | BRUNO JULIANNE | Chief Operating Officer | 21 Jun 2024 | Sale | 3,366 | 56.09 | 188,799 | D |
| 17 Apr 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 15 Apr 2024 | Sale | 1,204 | 60.4003 | 72,722 | D |
| 17 Apr 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 15 Apr 2024 | Sale | 18,378 | 59.8819 | 1,100,510 | D |
| 18 Mar 2024 17:45 | CRSP | CRISPR Therapeutics AG | PRASAD RAJU | Chief Financial Officer | 15 Mar 2024 | Sale | 3,524 | 72.69 | 256,160 | D |
| 18 Mar 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 15 Mar 2024 | Sale | 9,387 | 73.0604 | 685,818 | D |
| 18 Mar 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 15 Mar 2024 | Sale | 10,613 | 71.9693 | 763,810 | D |
| 12 Mar 2024 17:45 | CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 12 Mar 2024 | Sale | 1,146 | 74.44 | 85,308 | D |
| 12 Mar 2024 17:45 | CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 11 Mar 2024 | Sale | 2,801 | 78.26 | 219,206 | D |
| 12 Mar 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 12 Mar 2024 | Sale | 4,583 | 74.44 | 341,159 | D |
| 12 Mar 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 11 Mar 2024 | Sale | 9,802 | 78.26 | 767,105 | D |
| 21 Feb 2024 17:45 | CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 20 Feb 2024 | Sale | 1,913 | 79.67 | 152,409 | D |
| 21 Feb 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 20 Feb 2024 | Sale | 6,370 | 79.67 | 507,498 | D |
| 16 Feb 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 15 Feb 2024 | Sale | 5,951 | 81.0379 | 482,257 | D |
| 16 Feb 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 15 Feb 2024 | Sale | 1,100 | 81.6645 | 89,831 | D |
| 16 Feb 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 15 Feb 2024 | Sale | 12,949 | 79.9359 | 1,035,090 | D |
| 31 Jan 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 29 Jan 2024 | Sale | 700 | 61.0998 | 42,770 | D |
| 31 Jan 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 29 Jan 2024 | Sale | 49,300 | 60.5031 | 2,982,803 | D |
| 18 Jan 2024 17:45 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 16 Jan 2024 | Sale | 20,000 | 62.5029 | 1,250,058 | D |
| 01 Jun 2023 17:44 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 30 May 2023 | Sale | 2,400 | 66.8338 | 160,401 | D |
| 01 Jun 2023 17:44 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 30 May 2023 | Sale | 9,300 | 65.63 | 610,359 | D |
| 01 Jun 2023 17:44 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 30 May 2023 | Sale | 5,999 | 64.4577 | 386,682 | D |
| 01 Jun 2023 17:44 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 30 May 2023 | Sale | 7,301 | 63.6149 | 464,452 | D |
| 27 Apr 2023 17:37 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 25 Apr 2023 | Sale | 4,393 | 51.4503 | 226,021 | D |
| 27 Apr 2023 17:37 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 25 Apr 2023 | Sale | 20,607 | 50.4982 | 1,040,616 | D |
| 31 Mar 2023 17:49 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 29 Mar 2023 | Sale | 5,281 | 44.7844 | 236,506 | D |
| 31 Mar 2023 17:49 | CRSP | CRISPR Therapeutics AG | KULKARNI SAMARTH | Chief Executive Officer | 29 Mar 2023 | Sale | 19,719 | 44.3733 | 874,997 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)